 Optinose OPTN, a pharmaceutical company focused on patients treated by ear, nose and throat ENT and allergy specialists, today announced the Company will report financial results for the first quarter 2020 and corporate updates, after market close on Thursday, May 7, 2020. Members of the Companys leadership team will host a conference call to discuss financial results and corporate updates, including its launch of XHANCE. A simultaneous webcast of the call and presentation can be accessed by visiting the Investors section of Optinoses website at 